JANUMET (METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHO) — FDA Approval NDA022044 (MSD SUB MERCK)
JANUMET (METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHO) — FDA Approval NDA022044 (MSD SUB MERCK) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: JANUMET; Active ingredients: METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE; Application number: NDA022044.
| Brand name | JANUMET |
|---|---|
| Active ingredients | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE |
| Application number | NDA022044 |
| Sponsor | MSD SUB MERCK |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20070330 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →